ELENA BABLENIS HAVELES
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and
Prescription Writing
Haveles: Applied Pharmacology for the Dental Hygienist, 7th Edition
MULTIPLE CHOICE
1. Knowledge of pharmacology aids the dental professional in:
a. obtaining a patient’s health history.
b. administering drugs in the office.
c. handling emergency situations.
d. lifelong learning.
e. all of the above.
ANS: E
Correct: All of the choices are true.
Incorrect choices: Because many of our patients are being treated with drugs, knowledge of
pharmacology helps in understanding and interpreting patients’ responses to health history
questions. Knowledge of the therapeutic and adverse effects of medications obviously helps in
their proper administration in the office. Emergency situations may be caused by drugs or
treated by drugs; thus, knowledge of pharmacology is of great help, especially because a rapid
response is sometimes required. A clear understanding of the concepts of drug action, drug
handling by the body, and drug interactions will allow the dental practitioner to make proper
judgments and grasp the concepts relevant to new drug therapies on the market.
REF: Role of the Dental Hygienist | pp. 3-4 OBJ: 1
2. Which of the following statements is true regarding planning appointments?
a. Whether or not patients are taking medication for systemic diseases is of little
consequence in the dental office.
b. Asthmatic patients should have dental appointments in the morning.
c. Diabetic patients usually have fewer problems with a morning appointment
compared with afternoon appointments.
d. Both b and c are true.
ANS: C
Correct: Diabetic patients usually have relatively fewer problems with a morning
appointment.
Incorrect choices: Asthmatic patients should have afternoon appointments. Patients taking
medication for systemic diseases may require special handling in the dental office.
REF: Role of the Dental Hygienist (Appointment Scheduling) | p. 3
OBJ: 1
3. Nutritional or herbal supplements:
a. carry the U.S. Food and Drug Administration (FDA) approval for disease states.
b. are not drugs.
c. can cause adverse effects.
d. will not interact with other drugs the patient may be taking.
ANS: C
, Correct: Nutritional or herbal supplements are quite capable of causing adverse effects.
Incorrect choices: The majority of nutritional or herbal supplements do not carry FDA
approval for treating disease states. These supplements are drugs and can cause adverse
effects and interact with different drugs.
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) | pp. 3-4
OBJ: 1
4. Which type of drug name usually begins with a lowercase letter?
a. Brand name
b. Code name
c. Generic name
d. Trade name
ANS: C
Correct: Before any drug is marketed, it is given a generic name that becomes the “official”
name of the drug. Each drug is assigned only one generic name selected by the U.S. Adopted
Name Council, and the name is not capitalized.
Incorrect choices: The brand name is equivalent to the trade name and is capitalized. Although
the brand name is technically the name of the company marketing the product, this term is
often used interchangeably with the trade name. The code name is the initial term used within
a pharmaceutical company to refer to a drug while it is undergoing investigation and is often a
combination of capital letters and numbers, the letters representing an abbreviation of the
company name.
REF: Drug Names | p. 5 OBJ: 3
5. A drug’s generic name is selected by the:
a. pharmaceutical company manufacturing it.
b. Food and Drug Administration (FDA).
c. U.S. Adopted Name Council.
d. Federal Patent Office.
ANS: C
Correct: Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the
United States Adopted Name Council.
Incorrect choices: The generic name is not selected by the FDA or the Federal Patent Office.
The pharmaceutical company manufacturing the drug clearly has an influence on the generic
name given its drug, but the final decision is not the company’s.
REF: Drug Names | p. 5 OBJ: 4
6. Which of the following is true concerning generic and trade names of drugs?
a. A drug may only have one generic name and one trade name.
b. A drug may only have one generic name, but it may have several trade names.
c. A drug may have several generic names, but it may only have one trade name.
d. A drug may have several generic names and several trade names.
ANS: B
Correct: Each drug has only one generic name but may have several trade names.
, Incorrect zchoices: zFor zeach zdrug, zthere zis zonly zone zgeneric zname. zIt zis znot zcapitalized,
zand zit zbecomes zthe z“official” zname zof zthe zdrug. zThe zpharmaceutical zcompany zdiscovering
zthe zdrug zgives zthe zdrug za ztrade zname. zThe ztrade zname zis zprotected zby zthe zFederal zPatent
zLaw zfor z20 zyears zfrom zthe zearliest zclaimed zfiling zdate, zplus zpatent zterm zextensions.
zAlthough zthe zbrand zname zis ztechnically zthe zname zof zthe zcompany zmarketing zthe
zproduct, zit zis zoften zused zinterchangeably zwith zthe ztrade zname.
REF: z z Drug zNames z| zp. z4 OBJ: z z 3
7. Which zof zthe zfollowing zis zthe zmost zcommon zreference zbook zin zthe zdental zoffice?
a. United zStates zPharmacopeia-Drug zInformation z(USP zDI)
b. Physicians’ zDesk zReference z(PDR)
c. Mosby’s zDental zDrug zReference
d. Lexi-Comp’s zDrug zInformation zHandbook zfor zDentistry
ANS: z B
Correct: zThe zPDR zis zthe zmost zcommon zreference zbook zin zthe zdental zoffice zbecause zof zits
zhistorically zinexpensive zprice. zInformation zprovided zcomes zdirectly zfrom zthe zmanufacturer’s
zpackage zinsert.
Incorrect zchoices: zThe zUSP zDI zprovides zthe zhealth zprofessional zwith znecessary zinformation
zregarding zbasic zpharmacology zand zpharmacokinetics, zdosing, zadverse zreactions, zand zdrug
zinteractions. zMosby’s zDental zDrug zReference zprovides zaccess zto zinformation zon zdrugs
zcommonly ztaken zby zpatients. zLexi-Comp’s zDrug zInformation zHandbook zfor zDentistry
zcontains zconcise zlists zof zdrug zattributes zand zsections zrelevant zto zdentistry zfor zeach zdrug.
REF: z Box z1-2: zPharmacologic zReferences zand zResources zRecommended zfor zthe zDental zOffice z|
zp. z4 zOBJ: z 2
8. How zmany zyears zmust zpass zafter za zdrug zpatent zexpires zbefore zother zdrug zcompanies
zcan zmarket zthe zsame zcompound zas za zgeneric zdrug?
a. 20 zyears
b. 17 zyears
c. 7 zyears
d. 0 zyears
ANS: z D
Correct: zOnce za zdrug zpatent zexpires, zcompeting zcompanies zmay zimmediately zmarket zthe
zsame zcompound zin zgeneric zform.
Incorrect zchoices: zAfter z17 zyears, zthe zpatent zof zthe zoriginal zdrug zexpires, zand zother
zcompanies zcan zmarket zthe zsame zcompound zunder za zgeneric zname.
REF: z z Drug zNames z(Drug zSubstitution) z| zp. z5 OBJ: z z 4
9. Two zdrug zformulations zthat zproduce zsimilar zconcentrations zin zthe zblood zand ztissues zafter
zdrug zadministration zare ztermed z equivalent.
a. chemically
b. biologically
c. therapeutically
ANS: z B